Literature DB >> 15379902

Voltammetric study of the control of striatal dopamine release by glutamate.

Laura M Borland1, Adrian C Michael.   

Abstract

The central dopamine systems are involved in several aspects of normal brain function and are implicated in a number of human disorders. Hence, it is important to understand the mechanisms that control dopamine release in the brain. The striatum of the rat receives both dopaminergic and glutamatergic projections that synaptically target striatal neurons but not each other. Nevertheless, these afferents do form frequent appositional contacts, which has engendered interest in the question of whether they communicate with each other despite the absence of a direct synaptic connection. In this study, we used voltammetry in conjunction with carbon fiber microelectrodes in anesthetized rats to further examine the effect of the ionotropic glutamate antagonist, kynurenate, on extracellular dopamine levels in the striatum. Intrastriatal infusions of kynurenate decreased extracellular dopamine levels, suggesting that glutamate acts locally within the striatum via ionotropic receptors to regulate the basal extracellular dopamine concentration. Infusion of tetrodotoxin into the medial forebrain bundle or the striatum did not alter the voltammetric response to the intrastriatal kynurenate infusions, suggesting that glutamate receptors control a non-vesicular release process that contributes to the basal extracellular dopamine level. However, systemic administration of the dopamine uptake inhibitor, nomifensine (20 mg/kg i.p.), markedly decreased the amplitude of the response to kynurenate infusions, suggesting that the dopamine transporter mediates non-vesicular dopamine release. Collectively, these findings are consistent with the idea that endogenous glutamate acts locally within the striatum via ionotropic receptors to control a tonic, impulse-independent, transporter-mediated mode of dopamine release. Although numerous prior in vitro studies had suggested that such a process might exist, it has not previously been clearly demonstrated in an in vivo experiment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15379902     DOI: 10.1111/j.1471-4159.2004.02708.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  49 in total

1.  Tonic nanomolar dopamine enables an activity-dependent phase recovery mechanism that persistently alters the maximal conductance of the hyperpolarization-activated current in a rhythmically active neuron.

Authors:  Edmund W Rodgers; Jing Jing Fu; Wulf-Dieter C Krenz; Deborah J Baro
Journal:  J Neurosci       Date:  2011-11-09       Impact factor: 6.167

Review 2.  A review of the effects of FSCV and microdialysis measurements on dopamine release in the surrounding tissue.

Authors:  Andrea Jaquins-Gerstl; Adrian C Michael
Journal:  Analyst       Date:  2015-06-07       Impact factor: 4.616

3.  Behavioral correlates of activity in identified hypocretin/orexin neurons.

Authors:  Boris Y Mileykovskiy; Lyudmila I Kiyashchenko; Jerome M Siegel
Journal:  Neuron       Date:  2005-06-02       Impact factor: 17.173

Review 4.  Neurotransmitter receptor heteromers and their integrative role in 'local modules': the striatal spine module.

Authors:  Sergi Ferré; Luigi F Agnati; Francisco Ciruela; Carme Lluis; Amina S Woods; Kjell Fuxe; Rafael Franco
Journal:  Brain Res Rev       Date:  2007-01-27

5.  Impact of microdialysis probes on vasculature and dopamine in the rat striatum: a combined fluorescence and voltammetric study.

Authors:  Christina M Mitala; Yuexiang Wang; Laura M Borland; Moon Jung; Stuart Shand; Simon Watkins; Stephen G Weber; Adrian C Michael
Journal:  J Neurosci Methods       Date:  2008-07-15       Impact factor: 2.390

Review 6.  Electrochemical Analysis of Neurotransmitters.

Authors:  Elizabeth S Bucher; R Mark Wightman
Journal:  Annu Rev Anal Chem (Palo Alto Calif)       Date:  2015-05-04       Impact factor: 10.745

7.  Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface.

Authors:  Andrew H Miller
Journal:  Brain Behav Immun       Date:  2008-09-03       Impact factor: 7.217

8.  Key modulatory role of presynaptic adenosine A2A receptors in cortical neurotransmission to the striatal direct pathway.

Authors:  César Quiroz; Rafael Luján; Motokazu Uchigashima; Ana Patrícia Simoes; Talia N Lerner; Janusz Borycz; Anil Kachroo; Paula M Canas; Marco Orru; Michael A Schwarzschild; Diane L Rosin; Anatol C Kreitzer; Rodrigo A Cunha; Masahiko Watanabe; Sergi Ferré
Journal:  ScientificWorldJournal       Date:  2009-11-18

Review 9.  Immune system to brain signaling: neuropsychopharmacological implications.

Authors:  Lucile Capuron; Andrew H Miller
Journal:  Pharmacol Ther       Date:  2011-02-17       Impact factor: 12.310

10.  Chronic methylphenidate treatment enhances striatal dopamine neurotransmission after experimental traumatic brain injury.

Authors:  Amy K Wagner; Laura L Drewencki; Xiangbai Chen; F Ryan Santos; Amina S Khan; Rashed Harun; Gonzalo E Torres; Adrian C Michael; C Edward Dixon
Journal:  J Neurochem       Date:  2008-12-10       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.